CCTC award win
 Nov 26, 2025

CCTC wins 2025 AGITG Excellence in Site Performance Award

Last night, the Austin Health Cancer Clinical Trials Centre (CCTC) was recognised with the Australian Gastro-Intestinal Trials Group (AGITG) Excellence in Site Performance Award (Metropolitan), celebrating its outstanding contribution to gastro-intestinal cancer research and patient care.

The award, presented at the AGITG Annual Science Meeting in Adelaide, acknowledged the site that demonstrated exceptional commitment and performance in clinical trial conduct. It is the team’s second win in recent years, receiving a similar award in 2018, validating their continuous commitment and high-level of quality in clinical trial management and patient care.

CCTC has a long-standing partnership with AGITG, spanning more than 20 years encompassing numerous past landmark studies, as well as the ongoing VADER and BIL PPP trials. These trials are being conducted by Austin CCTC in partnership with Olivia Newton-John Cancer Research Institute (ONCRI) and the AGITG. This strong track record demonstrates the team’s commitment to advancing treatment options for cancer patients.

A key strength of the submission was CCTC’s inclusive approach with their creation of Is a clinical trial right for you? multilingual brochures and QR-coded posters located around the Olivia Newton-John Cancer and Wellness Centre to enhance awareness and accessibility for patients. These resources help patients make informed decisions about trial participation and are available on the ONJ Centre website

Anne-Marie Woods, Manager of CCTC, shared her delight in CCTC receiving this award.

“This award is a testament to the dedication, expertise, and collaborative spirit of our entire team. Their commitment to research excellence ensures patients receive world-class care and access to innovative treatments,” she said.

The Award was accepted in person by Meg Donovan-Hayes, Clinical Trials Nurse Coordinator and Professor Niall Tebbutt, Director of Medical Oncology at Austin Health and Gastro-Intestinal Principal Investigator (PI) lead. 

Well done to the whole team!

P1025343-edited